The 2016 NICE guidelines represent a paradigm shift by recommending coronary CTA as the first-line investigation for new onset stable chest pain, replacing previous pretest probability and calcium scoring strategies.
Answers are grounded in this paper and cite their sources.
Adopts CTCA-first without PTP scoring for stable chest pain; extends 2010 NICE guidance by simplifying pathways for clinicians and researchers.
Stable chest pain is a common clinical presentation that often requires further investigation using noninvasive or invasive testing, resulting in a resource-consuming problem worldwide. At onset of 2016, the National Institute for Health and Care Excellence (NICE) published an update on its guideline on chest pain. Three key changes to the 2010 version were provided by the new NICE guideline. First, the new guideline recommends that the previously proposed pretest probability risk score should no longer be used. Second, they also recommend that a calcium score of zero should no longer be used to rule out coronary artery disease (CAD) in patients with low pretest probability. Third, the new guideline recommends that all patients with new onset chest pain should be investigated with a coronary computed tomographic angiography (CTA) as a first-line investigation. However, in real world the impact of implementation of CTA for the evaluation of new onset chest pain remains to be evaluated, especially regarding its cost effectiveness. The aim of the present report was to discuss the results of the studies supporting new NICE guideline and its comparison with European and US guidelines.
No takes yet. Share an insight, caveat, or question.
Carrabba et al. (2018) studied this question.
Synapse has enriched 10 related papers. Consider them for comparative context: